Pharmacovigilance plays a crucial role for Marketing Authorization Holders (MAH) in ensuring the safety of medications after they are marketed. It involves monitoring, detecting, and assessing adverse drug reactions to identify potential risks.
Through rigorous data collection and continuous analysis, pharmacovigilance ensures that the benefits of treatments outweigh the risks, while implementing preventive measures if necessary.
This commitment to patient safety is fundamental to maintaining trust in available treatments.